IL1R1 and Huntington disease: Since both TNF and IL-1 stimulate the activation of JNK [16] (Figure 4A), we treated WT LCs in HD condition with IL1RA or anti-TNF individually or in combination for CFU assay in the presence or absence of the NF-κB inhibitor BAY for 12 hours and seeded them for CFU.